Purchase Order HT942525P0020

This is a $1,500,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services, to Cure Systems LLC, a self-certified small disadvantaged business located in Newton, Massachusetts. The contract is for the research and development of "Vector-Based Delivery of HIV Broadly Neutralizing Antibodies," a specialized approach to developing advanced...

<p>This is a $1,999,175.53 firm fixed-price Definitive Contract awarded by the Defense Health Agency (DHA), a defense agency, to Technovax Inc., a small disadvantaged business, under the SBIR (Small Business Innovation Research) Phase II program. The contract is for research and development work, with a period of performance ending on February 16, 2021. The contract was set aside for small businesses.</p>

This is a $300,000.00 firm-fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Cure Systems LLC, a small disadvantaged business located in Newton, MA. The contract is for the development of &quot;Vector-Based Delivery of HIV Broadly Neutralizing Antibodies&quot; and is related to NIAID's SBIR program objectives to stimulate technological...

This is a Firm Fixed Price contract awarded by the Defense Health Agency to Hexamer Therapeutics Inc., a self-certified small disadvantaged business, for $3,928,061.02. The contract is for research and development services related to a self-assembling vaccine platform, under a Broad Agency Announcement issued by the U.S. Army Medical Research and Development Command. The contract has an ultimate completion date of November 28, 2025 and was awarded on September 29, 2023. The original solicitation...

<p>This is a $148,402.94 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Sanaria, Inc. under the Small Business Innovation Research (SBIR) Phase II program. The contract is for &quot;Delivery System for Cryopreserved Eukaryotic Cell Vaccines&quot; research and development work, with a completion date of January 10, 2019. The contract was set aside for small businesses.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Acousticabio, Inc., a small business in Cambridge, MA. The contract, valued at $295,116, is for the development of &quot;HIGH-DOSE AND SUSTAINED DELIVERY OF HIV-1 BROADLY NEUTRALIZING ANTIBODIES VIA SUBCUTANEOUS INJECTION OF HYDROGEL-BASED MICROPARTICLE FORMATIONS&quot;. This contract is...

This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...

This is a Defense Health Agency (DHA) Small Business Innovation Research (SBIR) Phase II contract, awarded to X-Therma Inc., a minority-owned, small disadvantaged, economically disadvantaged women-owned small business. The contract has a total potential value of $998,967.41 and is a fixed-price level of effort contract. The research and development work will be performed in Vallejo, CA, with a completion date of May 24, 2020. This SBIR Phase II contract is a follow-on to a previous SBIR Phase...

<p>This is a $99,363.00 firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to American Hyperform, Inc., a small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and experimental development related to defense applications, with a performance location at Fort Belvoir, VA. The contract has a total small business set-aside designation and an ultimate completion date of July 20, 2021.</p>

<p>This is a $249,723.49 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Solaris Vaccines, Inc. under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of a &quot;VACCIRAPTOR: HIGH-THROUGHPUT, CONTINUOUS FLOW-THROUGH DEVICE FOR PSORALEN-UVA INACTIVATION OF DENGUE VIRUS.&quot; The contract has a total small business set-aside and an ultimate completion date of January 20, 2025.</p>